T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity

被引:2
作者
Canel, Marta [1 ]
Taggart, David [1 ]
Sims, Andrew H. [2 ]
Lonergan, David W. [1 ]
Waizenegger, Irene C. [3 ]
Serrels, Alan [1 ]
机构
[1] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Inst Genet & Mol Med, MRC, Canc Res UK,Edinburgh Ctr, Edinburgh, Midlothian, Scotland
[3] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
来源
ELIFE | 2020年 / 9卷
关键词
FOCAL-ADHESION KINASE; NEXT-GENERATION; PD-1; BLOCKADE; TUMOR-CELLS; TGF-BETA; CANCER; CD80; IMMUNOTHERAPY; COSTIMULATION; PROMOTES;
D O I
10.7554/elife.48092
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Focal Adhesion Kinase (FAK) inhibitors are currently undergoing clinical testing in combination with anti-PD-1 immune checkpoint inhibitors. However, which patients are most likely to benefit from FAK inhibitors, and what the optimal FAK/immunotherapy combinations are, is currently unknown. We identify that cancer cell expression of the T-cell co-stimulatory ligand CD80 sensitizes murine tumors to a FAK inhibitor and show that CD80 is expressed by human cancer cells originating from both solid epithelial cancers and some hematological malignancies in which FAK inhibitors have not been tested clinically. In the absence of CD80, we identify that targeting alternative T-cell co-stimulatory receptors, in particular OX-40 and 4-1BB in combination with FAK, can drive enhanced anti-tumor immunity and even complete regression of murine tumors. Our findings provide rationale supporting the clinical development of FAK inhibitors in combination with patient selection based on cancer cell CD80 expression, and alternatively with therapies targeting T-cell co-stimulatory pathways.
引用
收藏
页数:23
相关论文
共 54 条
[1]   Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation [J].
Adler, Adam J. ;
Vella, Anthony T. .
ONCOIMMUNOLOGY, 2013, 2 (01)
[2]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[3]   CONSTITUTIVE EXPRESSION OF B7 RESTORES IMMUNOGENICITY OF TUMOR-CELLS EXPRESSING TRUNCATED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES [J].
BASKAR, S ;
OSTRANDROSENBERG, S ;
NABAVI, N ;
NADLER, LM ;
FREEMAN, GJ ;
GLIMCHER, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5687-5690
[4]   A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours [J].
Beck, Benjamin ;
Driessens, Gregory ;
Goossens, Steven ;
Youssef, Khalil Kass ;
Kuchnio, Anna ;
Caauwe, Amelie ;
Sotiropoulou, Panagiota A. ;
Loges, Sonja ;
Lapouge, Gaelle ;
Candi, Aurelie ;
Mascre, Guilhem ;
Drogat, Benjamin ;
Dekoninck, Sophie ;
Haigh, Jody J. ;
Carmeliet, Peter ;
Blanpain, Cedric .
NATURE, 2011, 478 (7369) :399-+
[5]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[6]   Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies [J].
de Jonge, Maja J. A. ;
Steeghs, Neeltje ;
Lolkema, Martijn P. ;
Hotte, Sebastien J. ;
Hirte, Hal W. ;
van der Biessen, Diane A. J. ;
Razak, Albiruni R. Abdul ;
De Vos, Filip Y. F. L. ;
Verheijen, Remy B. ;
Schnell, David ;
Pronk, Linda C. ;
Jansen, Monique ;
Siu, Lillian L. .
TARGETED ONCOLOGY, 2019, 14 (01) :43-55
[7]   Phase I Study of the Focal Adhesion Kinase Inhibitor BI853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors [J].
Doi, Toshihiko ;
Yang, James Chih-Hsin ;
Shitara, Kohei ;
Naito, Yoichi ;
Cheng, Ann-Lii ;
Sarashina, Akiko ;
Pronk, Linda C. ;
Takeuchi, Yoshito ;
Lin, Chia-Chi .
TARGETED ONCOLOGY, 2019, 14 (01) :57-65
[8]   Robust anti-tumor immunity and memory in Rag-1-deficient mice following adoptive transfer of cytokine-primed splenocytes and tumor CD80 expression [J].
Ganesan, Priyadarshini L. ;
Alexander, Stephen I. ;
Watson, Debbie ;
Logan, Grant J. ;
Zhang, Geov Y. ;
Alexander, Ian E. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (12) :1955-1965
[9]   Next-generation characterization of the Cancer Cell Line Encyclopedia [J].
Ghandi, Mahmoud ;
Huang, Franklin W. ;
Jane-Valbuena, Judit ;
Kryukov, Gregory V. ;
Lo, Christopher C. ;
McDonald, E. Robert, III ;
Barretina, Jordi ;
Gelfand, Ellen T. ;
Bielski, Craig M. ;
Li, Haoxin ;
Hu, Kevin ;
Andreev-Drakhlin, Alexander Y. ;
Kim, Jaegil ;
Hess, Julian M. ;
Haas, Brian J. ;
Aguet, Francois ;
Weir, Barbara A. ;
Rothberg, Michael V. ;
Paolella, Brenton R. ;
Lawrence, Michael S. ;
Akbani, Rehan ;
Lu, Yiling ;
Tiv, Hong L. ;
Gokhale, Prafulla C. ;
De Weck, Antoine ;
Mansour, Ali Amin ;
Oh, Coyin ;
Shih, Juliann ;
Hadi, Kevin ;
Rosen, Yanay ;
Bistline, Jonathan ;
Venkatesan, Kavitha ;
Reddy, Anupama ;
Sonkin, Dmitriy ;
Liu, Manway ;
Lehar, Joseph ;
Korn, Joshua M. ;
Porter, Dale A. ;
Jones, Michael D. ;
Golji, Javad ;
Caponigro, Giordano ;
Taylor, Jordan E. ;
Dunning, Caitlin M. ;
Creech, Amanda L. ;
Warren, Allison C. ;
McFarland, James M. ;
Zamanighomi, Mahdi ;
Kauffmann, Audrey ;
Stransky, Nicolas ;
Imielinski, Marcin .
NATURE, 2019, 569 (7757) :503-+
[10]   Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80 [J].
Haile, Samuel T. ;
Bosch, Jacobus J. ;
Agu, Nnenna I. ;
Zeender, Annette M. ;
Somasundaram, Preethi ;
Srivastava, Minu K. ;
Britting, Sabine ;
Wolf, Julie B. ;
Ksander, Bruce R. ;
Ostrand-Rosenberg, Suzanne .
JOURNAL OF IMMUNOLOGY, 2011, 186 (12) :6822-6829